Skip to content

Change in Mindfulness in Borderline Personality Disorder

Change in Mindfulness in Borderline Personality Disorder After Dialectic-behavioural Therapy (DBT): A Pre-post-comparison

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03297840
Enrollment
30
Registered
2017-09-29
Start date
2017-05-04
Completion date
2017-12-31
Last updated
2017-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Borderline Personality Disorder, Mindfulness

Brief summary

The current study aims to investigate the effect of dialectical behavioral therapy on mindfulness in patients with Borderline Personality Disorder. A treatment group will be compared to a waitlist control group.

Detailed description

Participants will be recruited from the Dialectical-Behavioral-Therapy (DBT) unit. DBT is a treatment approach that has been shown to be effective in the treatment of Borderline Personality Disorder. DBT integrates different psychotherapeutic interventions as well as Mindfulness Meditation exercises. Mindfulness is a meditation practice that can improve present moment awareness. When applied as therapeutic intervention mindfulness meditation can help patients to stay with their attention in the present moment, to be aware what is happening in the here and now, and to better identify and regulate upcoming emotions. The current observational study investigates changes in symptom severity and mindfulness skills during DBT treatment. A treatment group will be compared to a waitlist control group. The two groups are predefined by routine medical care. Symptom severity and mindfulness skills will be assessed at baseline (before treatment or when accepted for the waitlist) and after 12-weeks. A within and between group analyses will be performed.

Interventions

BEHAVIORALDialectical Behavioural Therapy (DBT)

Inpatient Dialectical Behavioural Therapy (DBT) according to Linehan.

Sponsors

Katharina Bachmann
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Clinical diagnosis of Borderline Personality Disorder * On the waitlist for DBT treatment or actually treated with DBT * Not previously treated with DBT.

Exclusion criteria

* Severe psychiatric comorbidity e.g. psychosis, severe depression, suicidality

Design outcomes

Primary

MeasureTime frameDescription
Change in mindfulnessBaseline and after 12-weeksDegree of mindfulness will be assessed by the Kentucky Inventory of Mindfulness Skills, German Version (KIMS-D). A within and between group comparison will be performed (treatment vs. waitlist).
Change in borderline symptom severityBaseline and after 12-weeksChange in Borderline symptom severity is measured by the Borderline Symptom List (BSL 23). A within and between group comparison will be performed (treatment vs. waitlist).
Change in overall psychiatric symptom severityBaseline and after 12-weeksChange in overall symptom severity is measured by the Change in symptomseverity is measured by the Symptom-Checklist-90®-Standard (SCL-90). A within and between group comparison will be performed (treatment vs. waitlist).
Change in severity in symptoms of depressionBaseline and after 12-weeksChange in overall symptom severity is measured by the Beck depression inventory (BDI). A within and between group comparison will be performed (treatment vs. waitlist).

Countries

Germany

Contacts

Primary ContactKatharina Bachmann, Psych.Msc.
Katharina.Bachmann@uni-oldenburg.de00494119615 1506

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026